S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Bear market expert makes new prediction (Ad)
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
Buy THIS stock before Taiwan is attacked (Ad)
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
Buy THIS stock before Taiwan is attacked (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Bear market expert makes new prediction (Ad)
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
Buy THIS stock before Taiwan is attacked (Ad)
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
Buy THIS stock before Taiwan is attacked (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Bear market expert makes new prediction (Ad)
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
Buy THIS stock before Taiwan is attacked (Ad)
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
Buy THIS stock before Taiwan is attacked (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Bear market expert makes new prediction (Ad)
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
Buy THIS stock before Taiwan is attacked (Ad)
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
Buy THIS stock before Taiwan is attacked (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
NASDAQ:CVLB

Conversion Labs - CVLB Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$1.47
$1.73
50-Day Range
$14.48
$30.55
52-Week Range
$0.50
$33.02
Volume
129,507 shs
Average Volume
1.05 million shs
Market Capitalization
$39.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CVLB stock logo

About Conversion Labs (NASDAQ:CVLB) Stock

Conversion Labs, Inc. operates as a direct response healthcare company that provides over the counter products and prescription medications to consumers worldwide. The company's products include Shapiro MD, a shampoo, conditioner, and leave-in-foamer for treating hair loss; iNR Wellness MD, a nutritional supplement for immune and gut support; RexMD for the treatment of cold sores, mental health, and various other medical conditions faced by men; SOSRx, a telemedicine brand that offers prescription medications and over-the-counter emergency preparation supplies for disaster situations, such as flu epidemics, bacterial outbreaks, bioterrorism and water supply failures, and others; and PDFSimpli, a PDF conversion software enables users to convert, edit, and sign PDF documents. It markets and sells its products through advertisements on Facebook, Google, Amazon, and other social media and e-commerce platforms. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was founded in 1994 and is based in New York, New York.

Receive CVLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conversion Labs and its competitors with MarketBeat's FREE daily newsletter.

CVLB Stock News Headlines

What’s At Stake In April is Shocking
The Fed will be meeting on a topic that could change trading forever, and the decision could come as soon as the end of April. But by taking the smartest approach now, you can help shield your assets and work toward your trading goals. Time, as always, is of the essence. Click on this link to see what you need to do right away. pixel
CVLB_old Historical Data
LFMD
5 Hypergrowth Stocks to Buy Now
Luke Lango has found 14 stocks that have gone up over 1,000%. Now he’s named his top stocks for 2023. Just click to claim your copy. pixel
LifeMD Inc
Why Conversion Labs Stock Is Trading Higher Today
Conversion Labs reports Q3 prelim
See More Headlines
Receive CVLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conversion Labs and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Miscellaneous Manufacturing Industries
Sub-Industry
N/A
Current Symbol
NASDAQ:CVLB
CIK
N/A
Fax
N/A
Employees
26
Year Founded
N/A

Profitability

Net Income
$-3,140,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$12.47 million
Book Value
($0.11) per share

Miscellaneous

Free Float
N/A
Market Cap
$39.41 million
Optionable
Not Optionable
Beta
1.37

Key Executives

  • Mr. Justin Schreiber (Age 38)
    Pres, CEO & Chairman
    Comp: $52k
  • Mr. Juan Manuel Piñeiro Dagnery (Age 34)
    Chief Financial Officer
    Comp: $111.97k
  • Mr. Stefan Galluppi (Age 34)
    CTO & Director
    Comp: $111k
  • Mr. Sean Fitzpatrick (Age 38)
    Pres of LegalSimpli Software LLC
    Comp: $119.27k
  • Mr. Brad Roberts (Age 41)
    Chief Operating Officer
  • Mr. Eric H. Yecies (Age 43)
    Chief Compliance Officer & Gen. Counsel
  • Dr. Joseph V. DiTrolio (Age 70)
    Chief Medical Officer of US & Independent Director
  • Mr. Bryant Patrick Hussey
    Chief Digital Officer
  • Dr. Anthony David Puopolo II
    Chief Medical Officer













CVLB Stock - Frequently Asked Questions

What is Conversion Labs' stock symbol?

Conversion Labs trades on the NASDAQ under the ticker symbol "CVLB."

What is Conversion Labs' stock price today?

One share of CVLB stock can currently be purchased for approximately $1.70.

How much money does Conversion Labs make?

Conversion Labs (NASDAQ:CVLB) has a market capitalization of $39.41 million and generates $12.47 million in revenue each year.

How can I contact Conversion Labs?

Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The official website for the company is www.conversionlabs.com. The company can be reached via phone at (866) 351-5907 or via email at info@conversionlabs.com.

This page (NASDAQ:CVLB) was last updated on 4/2/2023 by MarketBeat.com Staff